2LJC

Structure of the influenza AM2-BM2 chimeric channel bound to rimantadine


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 75 
  • Conformers Submitted: 15 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses.

Pielak, R.M.Oxenoid, K.Chou, J.J.

(2011) Structure 19: 1655-1663

  • DOI: 10.1016/j.str.2011.09.003
  • Primary Citation of Related Structures:  
    2LJC, 2LJB

  • PubMed Abstract: 
  • The M2 channel of influenza A is a target of the adamantane family antiviral drugs. Two different drug-binding sites have been reported: one inside the pore, and the other is a lipid-facing pocket. A previous study showed that a chimera of M2 variants from influenza A and B that contains only the pore-binding site is sensitive to amantadine inhibition, suggesting that the primary site of inhibition is inside the pore ...

    The M2 channel of influenza A is a target of the adamantane family antiviral drugs. Two different drug-binding sites have been reported: one inside the pore, and the other is a lipid-facing pocket. A previous study showed that a chimera of M2 variants from influenza A and B that contains only the pore-binding site is sensitive to amantadine inhibition, suggesting that the primary site of inhibition is inside the pore. To obtain atomic details of channel-drug interaction, we determined the structures of the chimeric channel with and without rimantadine. Inside the channel and near the N-terminal end, methyl groups of Val27 and Ala30 from four subunits form a hydrophobic pocket around the adamantane, and the drug amino group appears to be in polar contact with the backbone oxygen of Ala30. The structures also reveal differences between the drug-bound and -unbound states of the channel that can explain drug resistance.


    Organizational Affiliation

    Jack and Eileen Connors Structural Biology Laboratory, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
M2 protein, BM2 protein chimeraA, B, C, D35Influenza A virus H3N2Influenza B virus (B/Taiwan/70061/2006)
This entity is chimeric
Mutation(s): 1 
Gene Names: BM2
Membrane Entity: Yes 
UniProt
Find proteins for B4UQM4 (Influenza B virus)
Explore B4UQM4 
Go to UniProtKB:  B4UQM4
Find proteins for Q9YP62 (Influenza A virus H3N2)
Explore Q9YP62 
Go to UniProtKB:  Q9YP62
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
RIM (Subject of Investigation/LOI)
Query on RIM

Download Ideal Coordinates CCD File 
E [auth A]RIMANTADINE
C12 H21 N
UBCHPRBFMUDMNC-RMPHRYRLSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 75 
  • Conformers Submitted: 15 
  • Selection Criteria: structures with the lowest energy 
  • OLDERADO: 2LJC Olderado

Structure Validation

View Full Validation Report




Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2011-11-16
    Type: Initial release
  • Version 1.1: 2012-03-21
    Changes: Database references